The IFN-γ/IL-10 ratio significantly differentiated patients with CIS from RRMS (AUC = 0.72) and RRMS and PPMS from HC (AUC = 0.76 and 0.71, respectively). The gene discussed is IFNG; the disease is in situ carcinoma.